Some hospital executives and cancer researchers sit on the boards of publicly traded companies, raising questions about whether their dual roles create a conflict of interest.
from news https://nyti.ms/2LHtkZM
via NYT Repost by newstimeweb
from news https://nyti.ms/2LHtkZM
via NYT Repost by newstimeweb